Lassa fever (patient information): Difference between revisions
Jump to navigation
Jump to search
| Line 30: | Line 30: | ||
==Prevention== | ==Prevention== | ||
* [[Primary transmission]] of the Lassa virus from its [[host]] to [[human]]s can be prevented by avoiding contact with Mastomys [[rodents]], especially in the geographic regions where outbreaks occur. Putting [[food]] away in rodent-proof containers and keeping the home clean help to discourage [[rodent]]s from entering homes. Using these [[rodent]]s as a food source is not recommended. Trapping in and around homes can help reduce rodent populations; however, the wide distribution of Mastomys in Africa makes complete control of this rodent reservoir impractical. When caring for patients with Lassa fever, further transmission of the disease through person-to-person contact or nosocomial routes can be avoided by taking preventive precautions against contact with patient secretions (called VHF isolation precautions or barrier nursing methods). Such precautions include wearing protective clothing, such as masks, gloves, gowns, and goggles; using infection control measures, such as complete equipment sterilization; and isolating infected patients from contact with unprotected persons until the disease has run its course. Further, educating people in high-risk areas about ways to decrease rodent populations in their homes will aid in the control and prevention of Lassa fever. Other challenges include developing more rapid diagnostic tests and increasing the availability of the only known drug treatment, ribavirin. Research is presently under way to develop a vaccine for Lassa fever. | * [[Primary transmission]] of the Lassa virus from its [[host]] to [[human]]s can be prevented by avoiding contact with Mastomys [[rodents]], especially in the geographic regions where outbreaks occur. Putting [[food]] away in rodent-proof containers and keeping the home clean help to discourage [[rodent]]s from entering homes. Using these [[rodent]]s as a food source is not recommended. Trapping in and around homes can help reduce [[rodent]] populations; however, the wide distribution of Mastomys in Africa makes complete control of this [[rodent]] [[reservoir]] impractical. When caring for [[patients]] with Lassa fever, further [[transmission]] of the [[disease]] through [[person-to-person]] contact or [[nosocomial routes]] can be avoided by taking preventive precautions against contact with patient secretions (called [[VHF isolation precautions]] or [[barrier nursing methods]]). Such precautions include wearing protective clothing, such as [[masks]], [[gloves]], [[gowns]], and [[goggles]]; using [[infection]] control measures, such as complete equipment [[sterilization]]; and isolating infected patients from contact with unprotected persons until the [[disease]] has run its course. Further, educating people in high-risk areas about ways to decrease [[rodent]] populations in their homes will aid in the control and prevention of Lassa fever. Other challenges include developing more rapid diagnostic tests and increasing the availability of the only known drug treatment, [[ribavirin]]. Research is presently under way to develop a [[vaccine]] for Lassa fever. | ||
==What to expect (Outlook/Prognosis)?== | ==What to expect (Outlook/Prognosis)?== | ||
Revision as of 03:21, 1 June 2015
|
Lassa fever |
|
Lassa fever On the Web |
|---|
For the WikiDoc page for this topic, click here
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
What are the symptoms of Lassa fever?
- Mild symptoms include slight fever, general malaise and weakness, and headache. In 20% of infected individuals, however, disease may progress to more serious symptoms including hemorrhaging (in gums, eyes, or nose, as examples), respiratory distress, repeated vomiting, facial swelling, pain in the chest, back, and abdomen, and shock. Neurological problems have also been described, including hearing loss, tremors, and encephalitis. Death may occur within two weeks after symptom onset due to multi-organ failure.
What causes Lassa fever?
- Lassa fever is caused by the Lassa virus, a member of the Arenaviridae family.
- The reservoir, or host, of Lassa virus is a rodent known as the "multimammate rat" (Mastomys natalensis). Once infected, this rodent is able to excrete virus in urine for an extended time period, maybe for the rest of its life. Mastomys rodents breed frequently, produce large numbers of offspring, and are numerous in the savannas and forests of west, central, and east Africa. In addition, Mastomys readily colonize human homes and areas where food is stored. All of these factors contribute to the relatively efficient spread of Lassa virus from infected rodents] to humans.
- Transmission of Lassa virus to humans occurs most commonly through ingestion or inhalation. Mastomysrodents shed the virus in urine and droppings and direct contact with these materials, through touching soiled objects, eating contaminated food, or exposure to open cuts or sores, can lead to infection.
Who is at highest risk?
- Individuals at greatest risk of Lassa virus infection are those who live in or visit endemic regions, including Sierra Leone, Liberia, Guinea, and Nigeria and have exposure to the multimammate rat. Risk of exposure may also exist in other west African countries where Mastomys rodents exist. Hospital staff are not at great risk for infection as long as protective measures and proper sterilization methods are used.
Diagnosis
- Lassa fever is most often diagnosed by using enzyme-linked immunosorbent serologic assays (ELISA), which detect IgM and IgG antibodies as well as Lassa antigen. Reverse transcription-polymerase chain reaction (RT-PCR) can be used in the early stage of disease. The virus itself may be cultured in 7 to 10 days, but this procedure should only be done in a high containment laboratory with good laboratory practices. Immunohistochemistry, performed on formalin-fixed tissue specimens, can be used to make a postmortem diagnosis.
When to seek urgent medical care?
Treatment options
- Ribavirin, an antiviral drug, has been used with success in Lassa fever patients. It has been shown to be most effective when given early in the course of the illness. Patients should also receive supportive care consisting of maintenance of appropriate fluid and electrolyte balance, oxygenation and blood pressure, as well as treatment of any other complicating infections.
Where to find medical care for Lassa fever?
Directions to Hospitals Treating Lassa fever
Prevention
- Primary transmission of the Lassa virus from its host to humans can be prevented by avoiding contact with Mastomys rodents, especially in the geographic regions where outbreaks occur. Putting food away in rodent-proof containers and keeping the home clean help to discourage rodents from entering homes. Using these rodents as a food source is not recommended. Trapping in and around homes can help reduce rodent populations; however, the wide distribution of Mastomys in Africa makes complete control of this rodent reservoir impractical. When caring for patients with Lassa fever, further transmission of the disease through person-to-person contact or nosocomial routes can be avoided by taking preventive precautions against contact with patient secretions (called VHF isolation precautions or barrier nursing methods). Such precautions include wearing protective clothing, such as masks, gloves, gowns, and goggles; using infection control measures, such as complete equipment sterilization; and isolating infected patients from contact with unprotected persons until the disease has run its course. Further, educating people in high-risk areas about ways to decrease rodent populations in their homes will aid in the control and prevention of Lassa fever. Other challenges include developing more rapid diagnostic tests and increasing the availability of the only known drug treatment, ribavirin. Research is presently under way to develop a vaccine for Lassa fever.